Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Huda Badri

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
The Journal of Allergy and Clinical Immunology. in Practice|July 8, 2019
Cough: New PharmacologyJaclyn A Smith, Huda Badri
Pulmonary Pharmacology & Therapeutics|October 18, 2019
Emerging targets for cough therapies; NK1 receptor antagonistsHuda Badri, Jaclyn A Smith
ERJ Open Research|January 21, 2025
Gastro-oesophageal reflux-related chronic cough: can new tools improve patient assessment?Shuxin Zhong, Ruchong Chen, Huda Badri
Neuroscience Letters|October 29, 2022
Mini-review: Hypertussivity and allotussivity in chronic cough endotypesJaclyn A Smith, Imran Satia, Huda Badri, et al.
Journal of Thoracic Disease|October 13, 2018
Airways diseases: asthma, COPD and chronic cough highlights from the European Respiratory Society Annual Congress 2018Imran Satia, Huda Badri, Lies Lahousse, et al.
Clinical Medicine (London, England)|December 14, 2016
Towards understanding and managing chronic coughImran Satia, Huda Badri, Bashar Al-Sheklly, et al.
Nature Reviews. Gastroenterology & Hepatology|July 7, 2016
Respiratory disease and the oesophagus: reflux, reflexes and microaspirationLesley A Houghton, Augustine S Lee, Huda Badri, et al.
Thorax|February 26, 2017
The interaction between bronchoconstriction and cough in asthmaImran Satia, Huda Badri, Mark Woodhead, et al.
Chest|August 18, 2019
The Neurokinin-1 Receptor Antagonist Orvepitant Is a Novel Antitussive Therapy for Chronic Refractory Cough: Results From a Phase 2 Pilot Study (VOLCANO-1)Jaclyn Smith, David Allman, Huda Badri, et al.
International Journal of Environmental Research and Public Health|March 28, 2024
HIPTox-Hazard Identification Platform to Assess the Health Impacts from Indoor and Outdoor Air Pollutant Exposures, through Mechanistic Toxicology: A Single-Centre Double-Blind Human Exposure Trial ProtocolThomas Faherty, Huda Badri, Dawei Hu, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
The Journal of Allergy and Clinical Immunology. in Practice|July 8, 2019
Cough: New PharmacologyJaclyn A Smith, Huda Badri
Pulmonary Pharmacology & Therapeutics|October 18, 2019
Emerging targets for cough therapies; NK1 receptor antagonistsHuda Badri, Jaclyn A Smith
ERJ Open Research|January 21, 2025
Gastro-oesophageal reflux-related chronic cough: can new tools improve patient assessment?Shuxin Zhong, Ruchong Chen, Huda Badri
Neuroscience Letters|October 29, 2022
Mini-review: Hypertussivity and allotussivity in chronic cough endotypesJaclyn A Smith, Imran Satia, Huda Badri, et al.
Journal of Thoracic Disease|October 13, 2018
Airways diseases: asthma, COPD and chronic cough highlights from the European Respiratory Society Annual Congress 2018Imran Satia, Huda Badri, Lies Lahousse, et al.
Clinical Medicine (London, England)|December 14, 2016
Towards understanding and managing chronic coughImran Satia, Huda Badri, Bashar Al-Sheklly, et al.
Nature Reviews. Gastroenterology & Hepatology|July 7, 2016
Respiratory disease and the oesophagus: reflux, reflexes and microaspirationLesley A Houghton, Augustine S Lee, Huda Badri, et al.
Thorax|February 26, 2017
The interaction between bronchoconstriction and cough in asthmaImran Satia, Huda Badri, Mark Woodhead, et al.
Chest|August 18, 2019
The Neurokinin-1 Receptor Antagonist Orvepitant Is a Novel Antitussive Therapy for Chronic Refractory Cough: Results From a Phase 2 Pilot Study (VOLCANO-1)Jaclyn Smith, David Allman, Huda Badri, et al.
International Journal of Environmental Research and Public Health|March 28, 2024
HIPTox-Hazard Identification Platform to Assess the Health Impacts from Indoor and Outdoor Air Pollutant Exposures, through Mechanistic Toxicology: A Single-Centre Double-Blind Human Exposure Trial ProtocolThomas Faherty, Huda Badri, Dawei Hu, et al.
Pageof 2